NCT03909464View on ClinicalTrials.gov

Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

November 25, 2019

Study Completion Date

November 25, 2019

Conditions
CancerMalignancyMalignant NeoplasmNeuropathyNeuropathies SensoryChemotherapy-induced Peripheral Neuropathy
Interventions
DEVICE

Neurosensory testing with Pressure-Specified Sensory Device

Patients will have neurosensory function of hands and feet tested with the non-invasive Pressure-Specified Sensory Device.

Trial Locations (1)

21205

Johns Hopkins University School of Medicine, Baltimore

Sponsors

Collaborators (1)

Axogen Corporation
All Listed Sponsors
collaborator

Axogen Corporation

INDUSTRY

collaborator

Johns Hopkins University

OTHER

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER